Home/Filings/4/0001144204-18-038180
4//SEC Filing

Wirostko Barbara 4

Accession 0001144204-18-038180

CIK 0001372514other

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 4:49 PM ET

Size

5.7 KB

Accession

0001144204-18-038180

Insider Transaction Report

Form 4
Period: 2018-07-10
Wirostko Barbara
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2018-07-10+175,000424,997 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    59,915
Footnotes (1)
  • [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001669087

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:49 PM ET
Size
5.7 KB